A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

NCT04527380 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Juvenile Psoriatic Arthritis
Enthesitis Related Arthritis

Interventions

DRUG: Ixekizumab
DRUG: Adalimumab

Sponsor

Eli Lilly and Company